View Author
cancer prostate prostate cancer screening biopsy study patient treatment surveillance survival gleason disease prostatectomy european randomized study follow-up group score erspc diagnosis number randomized result rotterdam value european table analysis stage level trial round progression screen outcome cohort tumor control arm control mortality antigen gleason score characteristic schroder fh therapy population urology range prostate cancer mortality contamination effect detection death roobol psa level roobol mj proportion psa-dt biopsy cores prostate cancers rotterdam section van der kwast grade family history prostate cancer screening screen-detected schroder prostate-speci fic antigen variable chapter rectal examination intervention arm metastatic disease relapse history metastatic overdiagnosi prognostic radiotherapy section roemeling
10 Most Recent Publications
|
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam).
(Article)
Kerkhof, M. Roobol, M.J. Cuzick, J. Sasieni, P. Roemeling, S. Schröder, F.H. Steyerberg, E.W. |
2010-12-01
|
|
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study
(Article)
Bergh, R.C.N. van den Vasarainen, H. Staerman, F. Oomens, E.H.G.M. Rannikko, A.S. Roemeling, S. Steyerberg, E.W. Roobol, M.J. Schröder, F.H. Bangma, C.H. Poel, H.G. van der Vis-Maters, J.J. Rietbergen, J.B. Pickles, T. Cornel, E.B. Valdagni, R. Jaspars, J.J. Hoeven, J. van der |
2010-04-01
|
|
Gleason score 7 screen-detected prostate cancers initially managed expectantly: Outcomes in 50 men
(Article)
Bergh, R.C.N. van den Roemeling, S. Roobol, M.J. Aus, G. Hugosson, J. Rannikko, A.S. Tammela, T.L. Bangma, C.H. Schröder, F.H. |
2009-06-01
|
|
Platinum Priority - Reply from Authors re: Peter C. Albertsen. The Treatment Paradigm Shifts Again on Prostate Cancer.
(Article)
Bergh, R.C.N. van den Roemeling, S. Roobol-Bouts, M.J. Aus, G. Hugosson, J. Rannikko, A.S. Tammela, T.L. Bangma, C.H. Schröder, F.H. |
2009-01-01
|
|
The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
(Article)
Gosselaar, C. Roobol, M.J. Roemeling, S. Schröder, F.H. |
2008-09-01
|
|
Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer-A Review
(Article)
Bergh, R.C.N. van den Roemeling, S. Roobol, M.J. Wolters, T. Schröder, F.H. Bangma, C.H. |
2008-09-01
|
|
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
(Article)
Gosselaar, C. Kranse, R. Roobol, M.J. Roemeling, S. Schröder, F.H. |
2008-06-15
|
|
The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer
(Article)
Gosselaar, C. Roobol, M.J. Roemeling, S. Wolters, T. Leenders, G.J. van Schröder, F.H. |
2008-03-01
|
|
Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?
(Article)
Wolters, T. Roobol, M.J. Schröder, F.H. Kwast, Th.H. van der Roemeling, S. Cruijsen-Koeter, I.W. van der Bangma, C.H. Leenders, G.J. van |
2008-02-01
|
|
Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
(Article)
Bergh, R.C.N. van den Roemeling, S. Roobol-Bouts, M.J. Aus, G. Hugosson, J. Rannikko, A.S. Tammela, T.L. Bangma, C.H. Schröder, F.H. |
2008-01-01
|
